[
DCMC Session
|
Presentation
]

Trends in Digital Maturity for Biomanufacturing | 2023 Digital CMC Summit On-Demand | Presentation

Why tightening alignment between digital initiatives and business goals is more critical than ever for drug developers

How people-focused approaches can help drug developers support the success of new technology investments

Why the industry is trading tech-driven digitization programs for tech-enabled business evolution strategies

Why and where successful transformation depends on culture, processes, and technology changing together

Dive into the digital dynamics shaping tomorrow's CMC landscape.

Despite a recent boom in purpose-built technologies, systems, and solutions, the biopharma sector is still working to catch up with many other science and engineering-driven industries. At the 2023 Digital CMC Summit, we asked three leading experts to share which trends, investments, and pressures are doing the most to help drug developers close the digital gap. In this deep-dive session:

  • Dr. Gloria Gadea Lopez, Head of Global Consultancy at Business Platforms, discusses the importance of aligning digital and business strategies, and how drug developers are working to ground their technology initiatives in real, tangible problems they can solve.
  • Oliver Hesse, VP & Head of Biotech Data Science & Digitalization at Bayer Pharmaceuticals, shares why the industry needs to rethink technology as a transformation driver, and shift its focus from digitizing processes to redesigning processes in ways that maximize the impact of digitalization.
  • Yash Sabharwal, President & CEO of QbDVision, adds his thoughts on the vital role education and training play in helping companies develop a data-centric digital culture that will accept and sustain transformation initiatives.

Register today to watch all three presentations and a live Q&A with the speakers.

Session speakers

6 photos

Watch this session

Legend
Legend
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

We’re here to help you deliver

No items found.
[
Biosystems Engineering
]

Gloria Gadea-Lopez

Gloria Gadea-Lopez is the Head of Global Consultancy at Business Platforms. Using her prior extensive experience in the biopharmaceutical industry, she supports companies in developing strategies and delivering digital systems for successful operations. She holds degrees in Chemical Engineering, Food Science (M.S.), and Biosystems Engineering (Ph.D.)

[
Bayer Pharmaceuticals
]

Oliver Hesse

Oliver Hesse is the current VP & Head of Biotech Data Science & Digitalization for Bayer, based in Berkeley, California. He has a degree in Biotechnology from TU Berlin and started his career in a Biotech start-up in Germany before joining Bayer in 2008 to work on automation, digitalization, and the application of data science in the biopharmaceutical industry.

[
QbDVision
]

Yash Sabharwal

Yash Sabharwal is an accomplished inventor, entrepreneur, and executive specializing in the funding and growth of early-stage technology companies focused on life science applications. He has started 3 companies and successfully exited his last two, bringing a wealth of strategic and tactical experience to the team.